| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,985 |
37,671 |
$2.04M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,235 |
24,755 |
$1.22M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,653 |
10,476 |
$805K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,240 |
9,101 |
$671K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,052 |
7,915 |
$575K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,211 |
3,073 |
$240K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,720 |
2,670 |
$202K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,602 |
1,579 |
$68K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,920 |
2,816 |
$44K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,822 |
1,760 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,310 |
1,086 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,213 |
1,966 |
$25K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
628 |
590 |
$18K |
| 96127 |
|
2,397 |
2,372 |
$9K |
| 96160 |
|
1,404 |
1,399 |
$4K |
| 99383 |
|
46 |
46 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
35 |
33 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$882.89 |
| 90686 |
|
7,157 |
6,446 |
$725.11 |
| 99188 |
|
37 |
37 |
$620.35 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$599.40 |
| 90700 |
|
8,879 |
8,385 |
$565.72 |
| 90670 |
|
5,412 |
5,149 |
$479.48 |
| 99000 |
|
270 |
162 |
$362.43 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
12 |
$204.90 |
| 90713 |
|
5,991 |
5,696 |
$131.54 |
| 90651 |
|
167 |
148 |
$116.93 |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
15 |
12 |
$96.13 |
| 90716 |
|
793 |
731 |
$91.30 |
| 90680 |
|
2,530 |
2,412 |
$88.97 |
| 90707 |
|
731 |
684 |
$86.89 |
| 90648 |
|
5,834 |
5,535 |
$80.99 |
| 90633 |
|
1,045 |
985 |
$73.62 |
| 90671 |
|
413 |
384 |
$15.43 |
| 90687 |
|
103 |
101 |
$15.09 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$1.92 |
| 90685 |
|
532 |
492 |
$0.00 |
| 90734 |
|
67 |
52 |
$0.00 |
| 99072 |
|
25 |
24 |
$0.00 |
| 90715 |
|
35 |
26 |
$0.00 |
| G9920 |
Screening performed and negative |
36 |
36 |
$0.00 |
| 90744 |
|
1,176 |
1,106 |
$0.00 |
| 90656 |
|
81 |
48 |
$0.00 |
| 90688 |
|
234 |
208 |
$0.00 |